BIOLASE Inc  

(Public, NASDAQ:BIOL)   Watch this stock  
Find more results for biol
2.17
+0.02 (0.93%)
Apr 24 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 2.12 - 2.27
52 week 1.69 - 3.00
Open 2.14
Vol / Avg. 155,600.00/154,997.00
Mkt cap 126.19M
P/E     -
Div/yield     -
EPS -0.47
Shares 58.15M
Beta 2.52
Inst. own 45%
Apr 30, 2015
Q1 2015 BIOLASE Inc Earnings Call - 4:30PM EDT - Add to calendar
Apr 30, 2015
Q1 2015 BIOLASE Inc Earnings Release Add to calendar
Apr 27, 2015
BIOLASE Inc Annual Shareholders Meeting - 2:00PM EDT - Add to calendar
Mar 4, 2015
Q4 2014 BIOLASE Inc Earnings Call - Webcast
Mar 4, 2015
Q4 2014 BIOLASE Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin -31.01% -39.71%
Operating margin -28.85% -37.65%
EBITD margin - -36.19%
Return on average assets -36.87% -41.85%
Return on average equity -61.95% -74.90%
Employees 210 -
CDP Score - -

Address

4 CROMWELL
IRVINE, CA 92618-1816
United States - Map
+1-949-3611200 (Phone)
+1-949-2736677 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

BIOLASE, Inc., formerly BIOLASE Technology, Inc., is a medical technology company that develops, manufactures and markets lasers, and markets and distributes dental imaging equipment and other related products designed for applications and procedures in dentistry and medicine. The Company's dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other specialists to perform a range of dental procedures, including cosmetic and complex surgical applications in a minimally invasive manner. The Company also manufactures and sells disposable products and accessories for its laser systems. The Company's Waterlase and Diode systems use disposable laser tips of differing sizes and shapes depending on the procedures being performed. The Company also markets flexible fibers and hands pieces. For the Company's ezlase system, it sells tooth whitening gel kits.

Officers and directors

Paul N. Clark Independent Chairman of the Board
Age: 66
Bio & Compensation  - Reuters
David C. Dreyer CPA Chief Financial Officer
Age: 58
Bio & Compensation  - Reuters
Brendan O'Connell Vice President - Finance and Corporate Controller
Age: 38
Bio & Compensation  - Reuters
Jeffrey M. Nugent President, Chief Executive Officer, Director
Age: 68
Bio & Compensation  - Reuters
George W. Bickerstaff III Director
Age: 59
Bio & Compensation  - Reuters
Tamar D. Howson Director
Age: 66
Bio & Compensation  - Reuters
Terence A. Kelly Ph.D. Director
Age: 53
Bio & Compensation  - Reuters
Jonathan T. Lord M.D. Director
Age: 59
Bio & Compensation  - Reuters
Frederic H. Moll M.D. Director
Age: 60
Bio & Compensation  - Reuters